Ritu Baral
Stock Analyst at TD Cowen
(3.82)
# 709
Out of 5,105 analysts
41
Total ratings
51.43%
Success rate
11.11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $231 → $269 | $197.01 | +36.54% | 6 | Dec 11, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $251 → $353 | $268.80 | +31.32% | 1 | Dec 8, 2025 | |
| VERA Vera Therapeutics | Maintains: Buy | $60 → $73 | $49.80 | +46.59% | 2 | Dec 5, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $65 → $97 | $98.58 | -1.60% | 2 | Nov 6, 2025 | |
| RNA Avidity Biosciences | Downgrades: Hold | $78 → $74 | $71.83 | +3.02% | 2 | Oct 29, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $35 → $39 | $27.15 | +43.65% | 2 | Sep 11, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $390 → $554 | $571.44 | -3.05% | 2 | Aug 26, 2025 | |
| SPRO Spero Therapeutics | Downgrades: Hold | n/a | $2.32 | - | 4 | Nov 18, 2024 | |
| ANTX AN2 Therapeutics | Downgrades: Hold | n/a | $1.20 | - | 2 | Nov 18, 2024 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $282 → $371 | $397.55 | -6.68% | 4 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.23 | - | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $175 | $21.53 | +712.82% | 1 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $83.40 | - | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $0.73 | - | 1 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $13.04 | - | 1 | Jul 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.29 | - | 2 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $45.00 | - | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.23 | - | 1 | Jun 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.46 | - | 2 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $564.28 | - | 2 | Jan 12, 2018 |
Insmed
Dec 11, 2025
Maintains: Buy
Price Target: $231 → $269
Current: $197.01
Upside: +36.54%
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $251 → $353
Current: $268.80
Upside: +31.32%
Vera Therapeutics
Dec 5, 2025
Maintains: Buy
Price Target: $60 → $73
Current: $49.80
Upside: +46.59%
Palvella Therapeutics
Nov 6, 2025
Maintains: Buy
Price Target: $65 → $97
Current: $98.58
Upside: -1.60%
Avidity Biosciences
Oct 29, 2025
Downgrades: Hold
Price Target: $78 → $74
Current: $71.83
Upside: +3.02%
ACADIA Pharmaceuticals
Sep 11, 2025
Maintains: Buy
Price Target: $35 → $39
Current: $27.15
Upside: +43.65%
Madrigal Pharmaceuticals
Aug 26, 2025
Maintains: Buy
Price Target: $390 → $554
Current: $571.44
Upside: -3.05%
Spero Therapeutics
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.32
Upside: -
AN2 Therapeutics
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.20
Upside: -
Alnylam Pharmaceuticals
Oct 21, 2024
Maintains: Buy
Price Target: $282 → $371
Current: $397.55
Upside: -6.68%
Aug 8, 2023
Initiates: Outperform
Price Target: n/a
Current: $6.23
Upside: -
Mar 22, 2023
Maintains: Outperform
Price Target: $125 → $175
Current: $21.53
Upside: +712.82%
Nov 23, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $83.40
Upside: -
Aug 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.73
Upside: -
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $13.04
Upside: -
Jul 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.29
Upside: -
Mar 2, 2021
Initiates: Outperform
Price Target: n/a
Current: $45.00
Upside: -
Jun 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.23
Upside: -
Jul 2, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $2.46
Upside: -
Jan 12, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $564.28
Upside: -